Top-News

ViewRay News

Keine aktuellen Kursdaten verfügbar
ISIN: US92672W1036
Typ: Aktie

ViewRay News

09.06.22 - PR Newswire
VA Ann Arbor Healthcare System Selects ViewRay to Expand Advanced Radiation Therapy Services
VA Ann Arbor Healthcare System Selects ViewRay to Expand Advanced Radiation Therapy Services PR Newswire
07.06.22 - PR Newswire
Shin-Matsudo Central General Hospital Select's ViewRay's MRIdian® MRI-Guided Radiation Therapy System to Expand Access to Precision Radiation Therapy
Shin-​Matsudo Central General Hospital Select's ViewRay's MRIdian® MRI-​Guided Radiation Therapy System to Expand Access to Precision Radiation Therapy PR Newswire
02.06.22 - PR Newswire
Henry Ford Health Becomes the First Center to Treat Patients with ViewRay's MRIdian A3i System
Henry Ford Health Becomes the First Center to Treat Patients with ViewRay's MRIdian A3i System PR Newswire
10.05.22 - PR Newswire
Clinical Value of MRIdian® MRI-Guided Radiation Therapy in the Treatment of Ultracentral/Central Lung Tumors Presented at ESTRO 2022
Clinical Value of MRIdian® MRI-​Guided Radiation Therapy in the Treatment of Ultracentral/Central Lung Tumors Presented at ESTRO 2022 PR Newswire
06.05.22 - PR Newswire
MRIdian Clinical and Research Experience Featured in Nearly 40 Abstracts at ESTRO 2022, the Leading European Radiation Oncology Meeting
MRIdian Clinical and Research Experience Featured in Nearly 40 Abstracts at ESTRO 2022, the Leading European Radiation Oncology Meeting PR Newswire
05.05.22 - PR Newswire
ViewRay Announces First Quarter 2022 Results
ViewRay Announces First Quarter 2022 Results PR Newswire
03.05.22 - PR Newswire
UCI Health Adopts ViewRay® MRIdian® MRI-Guided Radiation Therapy System
UCI Health Adopts ViewRay® MRIdian® MRI-​Guided Radiation Therapy System PR Newswire
21.04.22 - PR Newswire
ViewRay Announces Conference Call for First Quarter 2022 Financial Results to be Held After Market on May 5, 2022
ViewRay Announces Conference Call for First Quarter 2022 Financial Results to be Held After Market on May 5, 2022 PR Newswire
15.03.22 - PR Newswire
University Hospital Agostino Gemelli Treats its 1,000th Patient Using MRIdian® MRI-Guided Radiation Therapy
University Hospital Agostino Gemelli Treats its 1,000th Patient Using MRIdian® MRI-​Guided Radiation Therapy PR Newswire
10.03.22 - PR Newswire
ViewRay to Host a Virtual Clinical Data Event for Investors and Analysts on March 16, 2022
ViewRay to Host a Virtual Clinical Data Event for Investors and Analysts on March 16, 2022 PR Newswire
10.03.22 - PR Newswire
First Toxicity Results from SCIMITAR Prospective Phase II Trial Signal Favorable Toxicity Profile of Post-Prostatectomy Stereotactic Body Radiotherapy (SBRT) for Prostate Cancer
First Toxicity Results from SCIMITAR Prospective Phase II Trial Signal Favorable Toxicity Profile of Post-​Prostatectomy Stereotactic Body Radiotherapy (SBRT) for Prostate Cancer ...
09.03.22 - PR Newswire
ViewRay Enters into Cooperation Agreement with Hudson Executive Capital
ViewRay Enters into Cooperation Agreement with Hudson Executive Capital PR Newswire
24.02.22 - PR Newswire
ViewRay Announces Fourth Quarter and Full Year 2021 Results
ViewRay Announces Fourth Quarter and Full Year 2021 Results PR Newswire
15.02.22 - PR Newswire
Interim Findings from MIRAGE Phase III Randomized Trial Signal Superiority of MRIdian® MRI-guidance in Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer
Interim Findings from MIRAGE Phase III Randomized Trial Signal Superiority of MRIdian® MRI-​guidance in Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer ...
10.02.22 - PR Newswire
ViewRay® to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
ViewRay® to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference PR Newswire
10.02.22 - PR Newswire
ViewRay Announces Conference Call for Fourth Quarter and Full Year 2021 Financial Results to be Held After Market on February 24, 2022
ViewRay Announces Conference Call for Fourth Quarter and Full Year 2021 Financial Results to be Held After Market on February 24, 2022 PR Newswire
09.02.22 - PR Newswire
University Hospital Halle (Saale) Selects ViewRay's MRIdian® System to Broaden Advanced Radiation Therapy Treatment Services
University Hospital Halle (Saale) Selects ViewRay's MRIdian® System to Broaden Advanced Radiation Therapy Treatment Services MRIdian will be the First MRI-​guided Radiation ...
09.02.22 - PR Newswire
University Hospital Halle (Saale) Selects ViewRay's MRIdian® System to Broaden Advanced Radiation Therapy Treatment Services
University Hospital Halle (Saale) Selects ViewRay's MRIdian® System to Broaden Advanced Radiation Therapy Treatment Services PR Newswire
25.01.22 - PR Newswire
ViewRay® to Participate in the B. Riley Securities Oncology Conference
ViewRay® to Participate in the B. Riley Securities Oncology Conference PR Newswire
10.01.22 - PR Newswire
ViewRay Announces Preliminary Fourth Quarter and Full Year 2021 Results
ViewRay Announces Preliminary Fourth Quarter and Full Year 2021 Results PR Newswire

Newssuche

Videos

newspaper
09:30 Uhr +18,70%
Technical Trading: S&P 500 Short Chance
S&P 500 Short Typ: Turbo Open End WKN: NG8FUZ Hebel: 31 Laufzeit: OpenEnd Einstieg: Market ... Mehr »